An appeals court ruling that validated its fight against a deal by the gene-sequencing giant Illumina is a boost for the agency’s expansive antitrust strategy.
Read More internal-storyline-no, Antitrust Laws and Competition Issues, Federal Trade Commission, Khan, Lina, Illumina Inc, Grail Inc, Icahn, Carl C
